IRIS UniCatt

Cauda, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.219
EU - Europa 15.584
AS - Asia 13.225
SA - Sud America 2.524
AF - Africa 336
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 28
AN - Antartide 1
Totale 50.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.633
SG - Singapore 5.866
DE - Germania 4.722
CN - Cina 3.716
SE - Svezia 2.186
BR - Brasile 2.046
IT - Italia 2.011
FR - Francia 1.516
PL - Polonia 1.240
UA - Ucraina 1.179
VN - Vietnam 1.041
GB - Regno Unito 746
IE - Irlanda 614
IN - India 447
FI - Finlandia 406
ID - Indonesia 402
TR - Turchia 334
RU - Federazione Russa 318
JP - Giappone 307
CA - Canada 269
BD - Bangladesh 243
HK - Hong Kong 243
AR - Argentina 175
MX - Messico 172
NL - Olanda 121
IQ - Iraq 114
AT - Austria 104
ZA - Sudafrica 101
BE - Belgio 88
EC - Ecuador 85
ES - Italia 74
IR - Iran 57
CO - Colombia 56
MA - Marocco 55
VE - Venezuela 54
PK - Pakistan 52
KR - Corea 42
UZ - Uzbekistan 40
PH - Filippine 38
JO - Giordania 36
SA - Arabia Saudita 34
CL - Cile 33
TN - Tunisia 32
JM - Giamaica 31
CH - Svizzera 30
LT - Lituania 30
KE - Kenya 29
AU - Australia 26
CI - Costa d'Avorio 26
EG - Egitto 26
PY - Paraguay 24
EU - Europa 23
BG - Bulgaria 21
AZ - Azerbaigian 20
KZ - Kazakistan 20
MY - Malesia 20
UY - Uruguay 20
AE - Emirati Arabi Uniti 19
AL - Albania 19
CR - Costa Rica 19
CZ - Repubblica Ceca 19
NP - Nepal 19
GR - Grecia 17
PE - Perù 16
PT - Portogallo 16
BZ - Belize 14
DZ - Algeria 14
HN - Honduras 14
ET - Etiopia 13
IL - Israele 13
PA - Panama 13
RO - Romania 13
TW - Taiwan 13
BO - Bolivia 12
OM - Oman 12
DK - Danimarca 11
HU - Ungheria 11
LB - Libano 10
DO - Repubblica Dominicana 9
EE - Estonia 9
NG - Nigeria 9
AO - Angola 8
KG - Kirghizistan 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
GT - Guatemala 7
NI - Nicaragua 7
VA - Santa Sede (Città del Vaticano) 7
BH - Bahrain 6
LV - Lettonia 6
PR - Porto Rico 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
BY - Bielorussia 5
HR - Croazia 5
KW - Kuwait 5
LA - Repubblica Popolare Democratica del Laos 5
TT - Trinidad e Tobago 5
BB - Barbados 4
Totale 50.848
Salva come PNG Salva come JPEG
Città #
Singapore 2.973
Chandler 2.416
Ashburn 2.310
San Jose 1.614
Jacksonville 776
Warsaw 655
Hangzhou 634
New York 630
Dublin 603
Beijing 575
San Mateo 573
Kraków 551
Nanjing 438
Ann Arbor 394
Jakarta 371
Los Angeles 364
Dearborn 358
Ho Chi Minh City 348
Wilmington 348
Houston 345
Lauterbourg 336
Woodbridge 313
Milan 303
Nürnberg 295
Hefei 266
Rome 259
Tokyo 256
Boston 251
Hanoi 237
Izmir 233
The Dalles 214
Dallas 210
Hong Kong 210
Frankfurt am Main 195
Redmond 192
Lawrence 189
Moscow 188
Seattle 187
Cattolica 184
Fairfield 183
Nanchang 177
São Paulo 176
Munich 167
Marseille 153
Princeton 151
Chicago 148
Santa Clara 148
Buffalo 145
Redwood City 139
Lancaster 128
Boardman 119
Bremen 110
Shenyang 103
Helsinki 100
Kunming 91
Orem 85
Brussels 82
London 82
Mountain View 77
Hebei 75
Montreal 75
Norwalk 72
Rio de Janeiro 71
Tianjin 70
Toronto 70
Brooklyn 64
Cambridge 63
Paris 63
University Park 63
Atlanta 62
Kent 61
Vienna 61
Changsha 60
Johannesburg 60
Fremont 59
Guangzhou 59
Shanghai 57
Council Bluffs 56
Amsterdam 55
Da Nang 55
Nuremberg 55
Denver 54
Augusta 53
Leawood 53
Zhengzhou 52
Jiaxing 51
Phoenix 50
Pune 50
Düsseldorf 47
Memphis 47
Mexico City 47
Chennai 46
Belo Horizonte 43
Haiphong 43
Philadelphia 43
Washington 43
San Francisco 42
Turku 40
Manchester 39
North Bergen 39
Totale 26.626
Salva come PNG Salva come JPEG
Nome #
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 548
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 404
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 386
Factors associated with mortality in bacteremic patients with hematologic malignancies. 375
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 360
Factors associated with mortality in bacteremic patients with haematologic malignancies 357
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 357
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 332
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 329
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 311
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 298
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 281
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 270
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 265
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 265
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 264
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 256
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 240
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 240
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 231
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 231
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 228
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 225
Factors associated with mortality in bacteremic patients with hematologic malignancies. 219
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 219
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 219
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 218
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 216
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 214
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 211
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 211
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 210
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 208
COVID-19 atypical Parsonage-Turner syndrome: a case report 204
Malnutrition in COVID-19 survivors: prevalence and risk factors 204
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 204
A real-time integrated framework to support clinical decision making for covid-19 patients 204
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 199
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 199
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 197
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 197
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 195
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 195
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 195
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 195
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 192
Variability of raltegravir plasma levels in the clinical setting 192
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 191
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 190
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 190
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 189
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 188
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 188
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 187
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 185
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 185
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 185
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 185
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 183
Malnutrition in COVID-19 survivors: prevalence and risk factors 182
Psychopathological profile in COVID-19 patients including healthcare workers: the implications 180
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 180
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 180
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 179
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 179
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 178
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 178
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 178
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 177
Comparison of expression vectors in Lactobacillus reuteri strains 177
Initial antifungal strategy does not correlate with mortality in patients with candidemia 177
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 174
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 173
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 173
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 172
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis 172
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 171
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 171
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 170
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 169
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 169
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 169
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 168
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 167
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 166
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 166
Cognitive reserve and neuropsychological functioning in older HIV-infected people 165
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 165
Sarilumab use in severe SARS-CoV-2 pneumonia 165
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 165
Mortality in patients with early- or late-onset candidaemia 164
Attitudes and practices of dentists treating HIV patients in HAART era. 163
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 161
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 160
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 159
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 159
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 158
Totale 21.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.174 258 261 85 241 136 109 70 519 127 222 487 659
2022/20236.624 841 947 544 964 517 744 282 524 839 125 211 86
2023/20243.170 138 883 98 248 128 522 190 100 53 109 368 333
2024/20256.296 136 203 504 209 622 219 180 343 1.057 546 1.212 1.065
2025/202616.567 2.466 461 1.009 1.919 2.905 850 2.817 835 1.089 1.191 536 489
2026/2027418 418 0 0 0 0 0 0 0 0 0 0 0
Totale 51.480